Robertson Stephens Wealth Management, LLC

Position in MRNA — Moderna, Inc.

CIK 1767307 San Francisco, CA

Position in MRNA

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,028,180

+$273,546 QoQ

Shares Held

14,682

-1.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#295

of 772 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Robertson Stephens Wealth Management, LLC holds $4,144,185 across 13 Biotechnology names. MRNA ranks #1 (24.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	14,682	$1,028,180
2	ALNY	Alnylam Pharmaceuticals, Inc.	2,782	$837,465
3	INCY	Incyte Corp	6,672	$756,337
4	CTMX	CytomX Therapeutics, Inc.	96,000	$360,000
5	CUE	Cue Biopharma, Inc.	11,133	$351,357
6	VRTX	Vertex Pharmaceuticals Inc / Ma	420	$208,626
7	RLMD	Relmada Therapeutics, Inc.	25,000	$173,000
8	ACHV	Achieve Life Sciences, Inc.	25,000	$163,250

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,028,180	14,682	-1.2%	Shares	Sole	2026-07-29
2026-03-31	$754,634	14,855	-17.1%	Shares	Sole	2026-04-28
2025-12-31	$528,696	17,928	+858.7%	Shares	Sole	2026-02-02
2023-03-31	$287,194	1,870	+15.4%	Shares	Sole	2023-05-11
2022-12-31	$290,984	1,620	-2.9%	Shares	Sole	2023-02-14
2022-06-30	$238,416	1,669	+1.5%	Shares	Sole	2022-08-12
2022-03-31	$283,367	1,645	0.0%	Shares	Sole	2022-05-16
2021-12-31	$417,797	1,645	+12.5%	Shares	Sole	2022-02-14
2021-09-30	$562,665	1,462	+30.5%	Shares	Sole	2021-11-10
2021-06-30	$263,177	1,120	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.